ArticleNature communications2025
Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.
Abstract readPublished Erratum
In one paragraph
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
33 authors.
Lisa BertrandUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0002-9946-6075
Annika Nelde *Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0001-8504-8481
Bertha Cecilia Ramirez *Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0002-6670-9827
Isabelle Hatin *Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0002-4428-3079
Hugo ArbesUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0001-5718-6529
Pauline FrançoisUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.
Stéphane DemaisUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.
Emmanuel LabaronneLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.ORCID http://orcid.org/0000-0001-6314-7809
Didier DecimoCIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.ORCID http://orcid.org/0000-0002-0390-1205
Laura GuiguettazLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.
Sylvie GrégoireUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.
Anne BetSorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.
Guillaume BeauclairUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0001-5323-5987
Antoine GrossIRIM, UMR 9004, CNRS, Université de Montpellier, Montpellier, France.
Maja C ZieglerLeibniz Institute of Virology, Hamburg, Germany.
Mathias PereiraUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.
Raphaël Jeger-MadiotSorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.
Yann VerdierESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France.
Joelle VinhESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France.ORCID http://orcid.org/0000-0001-7184-2668
Sylvain CardinaudSorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.ORCID http://orcid.org/0000-0002-2650-1108
Stéphanie Graff-DuboisSorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.
Audrey EsclatineUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.
Cécile GouttefangeasInstitute of Immunology, University of Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0002-6410-2378
Marcus AltfeldLeibniz Institute of Virology, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5972-2997
Laurent HocquelouxCentre Hospitalier Universitaire d'Orléans, Orléans, France.ORCID http://orcid.org/0000-0002-2264-4822
Assia SamriSorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.
Brigitte AutranSorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.ORCID http://orcid.org/0000-0002-3993-9336
Olivier LambotteUniversité Paris Saclay, Inserm, CEA, AP-HP, UMR1184 IDMIT, Department of Internal Medicine & Clinical Immunology, Bicêtre Hospital, Le Kremlin-Bicêtre, Bicêtre, France.
Hans-Georg RammenseeInstitute of Immunology, University of Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0003-1614-2647
Emiliano P RicciLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.ORCID http://orcid.org/0000-0002-9789-5837
Juliane WalzDepartment of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0001-6404-7391
Olivier NamyUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. olivier.namy@i2bc.paris-saclay.fr.ORCID http://orcid.org/0000-0002-1143-5961
Arnaud MorisUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. arnaud.moris@i2bc.paris-saclay.fr.ORCID http://orcid.org/0000-0002-5052-1678
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.